VI-0810 is under development for the treatment of diabetes. Vivus, a subsidiary of Icahn Enterprises LP, is developing drugs for the treatment of exocrine pancreatic insufficiency, obesity and ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Detailed price information for Rio Tinto Plc ADR (RIO-N) from The Globe and Mail including charting and trades.

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

The World Bank in its latest report has highly appreciated the policies and the high tech moves of the Vietnam Government and ...

The global semiconductor industry is making headlines, fuelled by surging demand for electronic devices and groundbreaking ...

Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) ("Troilus” or the "Company”), is pleased to provide a recap of its ...

Brent is also at the heart of a number of proposed changes by Transport for London (TfL), including the creation of a new ...

AVITA Medical's Q3 report showed strong sequential sales growth and a lower burn rate. My confidence in it reaching breakeven ...

Signals from the incoming administration indicate a possible focus on policy pivots that they believe will result in a more ...

As 2024 ends, India’s AI sector has transitioned from its experimentation stage to strategic adoption, primarily driven by ...